Literature DB >> 10199530

Efficacy of silver-coating central venous catheters in reducing bacterial colonization.

A Bach1, H Eberhardt, A Frick, H Schmidt, B W Böttiger, E Martin.   

Abstract

OBJECTIVE: To compare silver-coated and uncoated central venous catheters regarding bacterial colonization. To assess the relative contribution of catheter hub and skin colonization to catheter tip colonization.
DESIGN: Prospective, randomized clinical trial.
SETTING: Intensive care unit in a university hospital. PATIENTS: Patients after cardiac surgery who required a central venous double-lumen catheter (DLC).
INTERVENTIONS: Sixty-seven adult patients were prospectively randomized to receive either a silver-coated (S group, n = 34) or an uncoated control (C group, n = 33) DLC. Blood cultures were drawn at catheter removal, and removed catheters were analyzed with quantitative cultures. Typing of microorganisms included DNA fingerprinting.
MEASUREMENTS AND MAIN RESULTS: Catheters were removed if no longer necessary and aseptically divided into three segments: segment A, the catheter tip; segment B, an intermediate section; and segment C, the subcutaneous portion. Bacterial catheter colonization was quantitatively measured using sonication to detach adherent bacteria from the catheter segments in the broth and subsequent culture of an aliquot. Selected isolates of coagulase-negative staphylococci and other bacteria from catheter segments were examined by means of pulsed-field gel electrophoresis (PFGE) after macrorestriction digestion of bacterial DNA to study colonization pathogenesis. Quantitatively lower bacterial colonization could be demonstrated on the silver-coated catheters (200 +/- 550 colony forming units [CFUs]/cm catheter segment; mean +/- SD). The difference in the control catheters (1120 +/- 5350 CFUs/cm catheter segment; mean +/- SD) was not, however, significant (p = .25). The frequency of colonization of at least one catheter segment was 52.9% for the silver-coated catheters and 57.6% for the control catheters (p= .44), without any significant differences in the colonization of corresponding catheter segments. The rate of significant catheter colonization (i.e., > or = 10(3) CFUs/cm catheter by quantitative catheter culture or > or = 10(3) CFUs/mL by luminal flush) was nine in the silver group and seven in the control group, a difference that failed to reach significance (p = .41). Two patients in both groups developed catheter-related bacteremia. Pattern analysis after PFGE demonstrated that about 70% of the isolates found on the catheter tip were identical with those on the skin at the insertion site, whereas about 75% were identical with those recovered from the hub. In 29% of colonized catheters, identical bacteria were found on the hub and the skin at the insertion site.
CONCLUSIONS: Silver-coating of DLCs did not significantly reduce bacterial catheter colonization compared with the control catheters. PFGE analysis of coagulase-negative staphylococci and other bacteria demonstrated various pathogenic routes of catheter-related colonization, whereby the microorganisms of the skin flora around the insertion site must be regarded as the main source of catheter-related infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199530     DOI: 10.1097/00003246-199903000-00028

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

Review 1.  Prevention of catheter-related bloodstream infection in patients on hemodialysis.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

2.  Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces.

Authors:  I Francolini; P Norris; A Piozzi; G Donelli; P Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 3.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

Review 4.  Use of silver in the prevention and treatment of infections: silver review.

Authors:  Amani D Politano; Kristin T Campbell; Laura H Rosenberger; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-02-28       Impact factor: 2.150

5.  Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.

Authors:  M N Carrasco; A Bueno; C de las Cuevas; S Jimenez; I Salinas; A Sartorius; T Recio; M Generelo; F Ruiz-Ocaña
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

6.  Clonal dissemination of Staphylococcus epidermidis in an oncology ward.

Authors:  Kenneth L Muldrew; Yi-Wei Tang; Haijing Li; Charles W Stratton
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

7.  Wild mushroom extracts as inhibitors of bacterial biofilm formation.

Authors:  Maria José Alves; Isabel C F R Ferreira; Inês Lourenço; Eduardo Costa; Anabela Martins; Manuela Pintado
Journal:  Pathogens       Date:  2014-08-06

8.  Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation.

Authors:  Yoon Ji Choi; Jae Kwan Lim; Jeong Jun Park; Hyub Huh; Dong-Joo Kim; Chang-Hoon Gong; Seung Zhoo Yoon
Journal:  J Int Med Res       Date:  2017-05-23       Impact factor: 1.671

Review 9.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16

10.  Impact of catheter antimicrobial coating on species-specific risk of catheter colonization: a meta-analysis.

Authors:  Aleksey Novikov; Manuel Y Lam; Leonard A Mermel; Anna L Casey; Tom S Elliott; Peter Nightingale
Journal:  Antimicrob Resist Infect Control       Date:  2012-12-03       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.